Pakistan’s drug regulatory agency has approved final-phase testing of a Chinese-made vaccine against Covid-19.

In a statement on Monday (Aug 17), the state-run National Institute of Health said the approval to carry out advanced clinical trials for potential Covid-19 was granted by Drug Regulatory Authority of Pakistan.

It said the phase-3 clinical trials for a candidate vaccine against the new virus will be conducted at the country’s main health facilities.

It said the vaccine was produced by CanSinoBio, a China-based vaccine developer and Beijing Institute of Biotechnology.

Pakistan, which has witnessed a steady decline in fatalities from the new virus, reported only 15 new Covid-19 deaths and 617 new cases in the past 24 hours. It has reported 289,832 cases since February when the first infection was detected in the country. (AP)

If you want to share your stories and/or experiences with us, please send an email to [email protected]